Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Jan 31.

Published in final edited form as: Microcirculation. 2015 Feb;22(2):109–121. doi: 10.1111/micc.12183

TABLE 3.

Biophysical Parameters for Cerebral and LAD VSMCs

	E_Rev	V_1/2
Cerebral VSMCs
Control	−33.9 ± 1.3	23.3 ± 1.9
+ Retigabine	−37.4 ± 1.2^*	16.2 ± 1.8^*
Retigabine sensitive^#		6.7 ± 0.9
Control	−36.9 ± 1.1	20.7 ± 1.1
+ Linopirdine	−32.2 ± 1.4^*	26.4 ± 1.4^*
Linopirdine sensitive^#		8.9 ± 2.7
LAD SMCs
Control	−35.5 ± 2.3	15.6 ± 1.7
+ Retigabine	−37.3 ± 2.5	15.1 ± 1.3
Control	−38.7 ± 1.3	15.5 ± 1.6
+ Linopirdine	−37.7 ± 2.1	17.5 ± 2.2

^#

sensitive components calculated by subtraction of control data and that obtained in the presence or either retigabine or linopirdine

^*

p < 0.05 compared to control recording (paired t-test)